NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
Revenue
NeoPharm Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Revenue
₩101.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
17%
|
AmorePacific Corp
KRX:090430
|
Revenue
₩3.7T
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
1%
|
|
Amorepacific Group
KRX:002790
|
Revenue
₩4T
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
Cosmax Inc
KRX:192820
|
Revenue
₩1.8T
|
CAGR 3-Years
9%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
LG H&H Co Ltd
KRX:051900
|
Revenue
₩6.8T
|
CAGR 3-Years
-5%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Revenue
₩2.2T
|
CAGR 3-Years
18%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
See Also
What is NeoPharm Co Ltd's Revenue?
Revenue
101.7B
KRW
Based on the financial report for Mar 31, 2024, NeoPharm Co Ltd's Revenue amounts to 101.7B KRW.
What is NeoPharm Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
17%
Over the last year, the Revenue growth was 18%. The average annual Revenue growth rates for NeoPharm Co Ltd have been 6% over the past three years , 8% over the past five years , and 17% over the past ten years .